Frail elderly patients with relapsed-refractory multiple myeloma: efficacy and toxicity profile of the combination of bortezomib, high-dose dexamethasone, and low-dose oral cyclophosphamide

被引：12
作者：
Mele, Giuseppe [1 ]
Giannotta, Angela
Pinna, Salvatore
Loseto, Giacomo
Coppi, Maria Rosaria
Brocca, Claudio Maurizio
Melpignano, Angela
Quarta, Giovanni
机构：
[1] Antonio Perrino Hosp, Clin Div Hematol, I-72100 Brindisi, Italy
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 05期
关键词：
PREDNISONE PLUS THALIDOMIDE; MELPHALAN;
D O I：
10.3109/10428191003695660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：937 / 940
页数：4
相关论文
共 13 条
  • [1] Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224
  • [2] Continuous low-dose cyclophosphamide-prednisone is effective and well tolerated in patients with advanced multiple myeloma
    de Weerdt, O
    van de Donk, NWCJ
    Veth, G
    Bloem, AC
    Hagenbeek, A
    Lokhorst, HM
    [J]. NETHERLANDS JOURNAL OF MEDICINE, 2001, 59 (02) : 50 - 56
  • [3] DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO
  • [4] 2-U
  • [5] Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial
    Facon, Thierry
    Mary, Jean Yves
    Hulin, Cyrille
    Benbouker, Lofti
    Attal, Michel
    Pegourie, Brigitte
    Renaud, Marc
    Guillerm, Jean Luc Harousseau Gaelle
    Ahletaix, Carine
    Dib, Mamoun
    Voillat, Laurent
    Maisonneuve, Herve
    Troncy, Jacques
    Dervaux, Weronique
    Monconduit, Mathieu
    Martin, Claude
    Casassus, Philippe
    Jaubert, Jerome
    Jardel, Henry
    Doyen, Chantal
    Kolb, Brigitte
    Anglaret, Bruno
    Grosbois, Bernard
    Yakoub-Agha, Ibrahim
    Mathiot, Claire
    Avet-Loiseau, Herve
    [J]. LANCET, 2007, 370 (9594) : 1209 - 1218
  • [6] Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial
    Hulin, Cyrille
    Facon, Thierry
    Rodon, Philippe
    Pegourie, Brigitte
    Benboubker, Lotfi
    Doyen, Chantal
    Dib, Mamoun
    Guillerm, Gaelle
    Salles, Bruno
    Eschard, Jean-Paul
    Lenain, Pascal
    Casassus, Philippe
    Azais, Isabelle
    Decaux, Olivier
    Garderet, Laurent
    Mathiot, Claire
    Fontan, Jean
    Lafon, Ingrid
    Virion, Jean Marc
    Moreau, Philippe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (22) : 3664 - 3670
  • [7] Kropff M, 2005, BLOOD, V106, p716A
  • [8] PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma
    Oakervee, HE
    Popat, R
    Curry, N
    Smith, P
    Morris, C
    Drake, M
    Agrawal, S
    Stec, J
    Schenkein, D
    Esseltine, DL
    Cavenagh, JD
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (06) : 755 - 762
  • [9] Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial
    Palumbo, Antonio
    Bringhen, Sara
    Liberati, Anna M.
    Caravita, Tommaso
    Falcone, Antonietta
    Callea, Vincenzo
    Montanaro, Marco
    Ria, Roberto
    Capaldi, Antonio
    Zambello, Renato
    Benevolo, Giulia
    Derudas, Daniele
    Dore, Fausto
    Cavallo, Federica
    Gay, Francesca
    Falco, Patrizia
    Ciccone, Giovannino
    Musto, Pellegrino
    Cavo, Michele
    Boccadoro, Mario
    [J]. BLOOD, 2008, 112 (08) : 3107 - 3114
  • [10] Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myeloma
    Reece, Donna E.
    Rodriguez, Giovanni Piza
    Chen, Christine
    Trudel, Suzanne
    Kukreti, Vishal
    Mikhael, Joseph
    Pantoja, Mariela
    Xu, Wei
    Stewart, A. Keith
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) : 4777 - 4783
12